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Jose´ A. Avile´s5, Miguel A´. del Pozo6, Amaya Puig-Kro¨ger2,7 and Paloma Sa´nchez-Mateos1,2,7
To understand factors that regulate leukocyte entry and positioning within human melanoma tissues,
we performed a multiparametric quantitative analysis of two separated regions: the intratumoral area and the
peritumoral stroma. Using two mesenchymal markers, fibroblast activation protein (FAP) and CD90, we identified
three subsets of mesenchymal cells (MCs): (i) intratumoral FAPþCD90low/ MC, (ii) peritumoral FAPþCD90þ MC,
and (iii) FAPCD90þ perivascular MC. We characterized CD90þ MCs, which showed a stable CCL2-secretory
phenotype when long-term expanded ex vivo, and heavily surrounded peritumoral Duffy antigen receptor for
chemokineþ (DARC) postcapillary venules, supporting a role for these vessels in peritumoral inflammatory
leukocyte recruitment. Conversely, the intratumoral area was variably invaded by FAPþCD90low/ MCs that
colocalized with a distinct extracellular matrix (ECM) network. A positive correlation was observed between
intratumoral stromal cell/ECM networks and leukocyte infiltration among tumor cells (TCs), as well as in a stroma-
dependent xenograft tumor model. Adoptively transferred T lymphocytes preferentially infiltrated tumors
composed of TCþMC, compared with TCs only. Altogether, our results suggest that a variety of MCs contribute
to regulate different steps of leukocyte tumor infiltration, that is, CD90þ cells surrounding peritumoral vessels
secrete CCL2 to recruit CCR2þ leukocytes at the tumor periphery, whereas intratumoral FAPþ cells organize a
stromal scaffold that contact guide further invasion among densely packed tumor cells.
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INTRODUCTION
Tumors are complex tissues that often contain an inflamma-
tory milieu, composed of immune cells and their secretory
products, which influences almost every aspect of cancer
biology and progression (Biswas and Mantovani, 2010).
Chemokines and their receptors have an important role in
the recruitment of inflammatory cells into the tumor
microenvironment (Allavena et al., 2011). Particularly, CCL2
has been identified as the major factor driving recruitment of
inflammatory monocytes, which highly express its receptor
CCR2 (Qian et al., 2011), and other CCR2þ leukocytes
such as CD8þ effector and CD4þ regulatory T lymphocytes
(Brown et al., 2007; Fridlender et al., 2010) and myeloid-
derived suppressor cells (Huang et al., 2007). CCL2 has
both a pro-tumorigenic and pro-metastatic role in cancer, as
evidenced by the different effects observed on tumor-bearing
mice after systemic blockade of CCL2 (Gazzaniga et al., 2007;
Fujimoto et al., 2009; Lu and Kang, 2009; Fridlender et al.,
2010; Qian et al., 2011).
After tissue homing and extravasation, leukocytes are able
to perform interstitial migration within lymphoid or peripheral
tissues, migrating along substrates such as cellular networks or
fibrillar extracellular matrix (ECM) (Friedl and Weigelin, 2008;
Mrass et al., 2010). In tumors, ECM deposition and leukocyte
infiltration are very pronounced at the tumor–stroma border
(Weishaupt et al., 2007; Egeblad et al., 2010). Mounting
evidence in mouse models suggests that leukocytes are first
recruited at the tumor periphery to eventually initiate the
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infiltration of deeper tumor regions (Lin et al., 2006;
Boissonnas et al., 2007; Celli et al., 2011). Several in vivo
studies have shown that, rather than a general chemokine-
guided infiltration, cytotoxic lymphocytes perform random
migration that may lead to a progressive infiltration of solid
tumors, sometimes along ECM fibers, as determined by second
harmonic generation microscopy (Mrass et al., 2006;
Boissonnas et al., 2007). Therefore, it might be possible that
intratumoral fibrous ECM make tumors more conducive for
immune infiltration (Yang et al., 2006; Mrass et al., 2010).
Interestingly, it has been shown in a model of induced
encephalitis that the movement of infiltrating lymphocytes is
closely associated with a reticular fiber network formed in the
course of infection (Wilson et al., 2009). We performed a
multiparametric confocal analysis of human melanoma tissues
to position infiltrating leukocytes within anatomical sub-
compartments at the tumor site. We identified a special type
of tumor-associated mesenchymal cells (MCs) producing high
amounts of CCL2 around the peritumoral postcapillary veins,
which are the preferential sites of leukocyte homing.
Remarkably, we realized that the intratumoral position of
leukocytes was closely associated with the existence of a
distinct mesenchymal fibro-cellular network among densely
packed tumor cells (TCs).
RESULTS
Cellular and matrix components of the human metastatic
melanoma microenvironment
We used immunofluorescence labeling to position leukocytes
within the human melanoma tumor tissue. To systematize our
study, we analyzed separately the intratumoral and the
peritumoral regions, using a panel of tumor, mesenchymal
(cells and matrix), endothelial, and leukocyte markers
(Supplementary Table S1 online). Figure 1a illustrates tumoral
and peritumoral domains of a subcutaneous melanoma
metastasis, from an advanced stage IV patient. Peritumoral
vessels were generally larger than intratumoral capillaries and
displayed tall endothelial cells expressing Duffy antigen recep-
tor for chemokine (DARC), whereas intratumoral vessels
were DARC-negative (20/22 metastases, Figure 1aA–D and b;
Supplementary Figure S2a online). Consistently, uncountable
CD45þ leukocytes, mainly T lymphocytes and macrophages,
localized around these vessels adjacent to the tumor and
accumulated at the tumor–stoma border (Figure 1aE–F;
Supplementary Figure S2b online), whereas intratumoral
leukocytes were less frequent and variably distributed.
To search for factors affecting the intratumoral position of
leukocytes, we quantified CD45þ cells deeply infiltrating
among TCs in 22 melanoma metastasis and nine thick primary
Tumor
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vWF FAP CD90 vWF FAP
PeritumoralPeritumoral 50 μm50 μm
CD31 DARC
vWF CD90
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FAP vWF
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Figure 1. Tumor microenvironment imaged by multicolor fluorescence
microscopy. (a) Subcutaneous melanoma metastasis (no. 223) stained as
follows: (A) NG2 (white), CD31 (red), and nuclei (blue); (B) CD31 (red) and
Duffy antigen receptor for chemokine (DARC) (green); (C) von Willebrand
factor (vWF) (red) and CD90 (green); (D) vWF (red) and fibroblast activation
protein (FAP) (white). (E) Type I collagen (COL1) (red) and CD68 (white); and
(F) CD45 (white). Panels are composites of three adjacent fields imaged at
original magnification  10. (b, c) Magnified peritumoral vessels stained for
CD31 (red) and DARC (green); and vWF (white), FAP (red), and CD90 (green),
respectively. Scale bars, as indicated. DAPI, 40,6-diamidino-2-phenylindole.
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melanomas (Supplementary Table S3 online). Intratumoral
leukocytes were preferentially macrophages and CD8
T cells, with less CD4 and B lymphocytes (Supplementary
Figure S2c online).
Using the mesenchymal markers fibroblast activation
protein (FAP) and CD90, we distinguished three MC subsets:
(i) FAPþCD90low/ MCs within the intratumoral area,
(ii) FAPþCD90þ -elongated MCs within peritumoral stroma,
and (iii) FAPCD90hi perivascular MCs or pericytes
(Figure 1aC,D and c). Similar to the heterogeneity of intratu-
moral leukocytes, there were great variations in the presence
of (i) FAPþCD90 MCs within the intratumoral compartment.
Each patient specimen was categorized on the basis of
FAPþCD90 MC intratumoral content in two groups (Supple-
mentary Table S3 online): no significant infiltration (o3%
FAP-stained area, Supplementary Figure S2d) and intermedi-
ate/high infiltration (43%, Figure 1a; Supplementary
Figure S2e). Interestingly, in FAPþ -infiltrated specimens, an
organized fibrillar network composed of type I collagen
(COL1) and fibronectin (FN) was detected among densely
packed TCs, colocalizing with intratumoral FAPþCD90
MCs (Figure 1aE; Supplementary Figure S2f and g online).
These cells were smooth muscle actin-negative in most cases
(21/22 metastases, Supplementary Figure S2h online), com-
pared with peritumoral stroma elongated (ii) FAPþCD90þ
MCs, which frequently expressed smooth muscle actin (Goetz
et al., 2011). Mesenchymal CD90 expression was limited to
the peritumoral stroma, fading away at the tumor–stroma
border in all analyzed samples (Figures 1aC; Supplementary
Figure S2e and g online). In addition to the elongated FAPþ
CD90þ MCs, most peritumoral vessels (B80%) were mark-
edly surrounded by (iii) FAP-CD90hi perivascular cells that
virtually did not exist around intratumoral vessels (Figure 1aC;
Supplementary Figure S2a and i online), which is consistent
with the absence of pericytes around tumor vessels in
melanoma (Helfrich et al., 2010). These findings suggest the
existence of heterogeneous MC subpopulations within tumor
and peritumoral stroma.
MC produce CCL2 ex vivo and around peritumoral vessels
To characterize MCs, we purified melanoma-associated MCs
by high CD90 or FAP expression (Supplementary Figure S4a
online); however, only CD90þ -sorted cells were efficiently
expanded in culture, persistently expressing CD90 and FAP
(Figure 2a; Supplementary Table S5). Long-term expanded
CD90þ cells lacked melanoma antigens (S100, Hmb45, and
Melan-A) and expressed CD105, CD146, and NG2 pericyte/
mesenchymal markers (Supplementary Table S5 online).
To confirm their mesenchymal origin, CD90þ cells were first
tested for their ability to produce and organize three-dimen-
sional matrices. CD90þ cells readily produced matrices rich
in FN, compared with the corresponding patient-derived TCs
(Figure 2a). Next, we explored their ability to attract peripheral
blood leukocytes in transwell and transendothelial migration
assays (Figure 2b; Supplementary Figure S4b online).
All conditioned media from MCs isolated from six patients
considerably induced the preferential migration of monocytes
(B15 fold), compared with lymphocytes. The secretion
of various chemokines that are chemotactic for human
monocytes was assessed and we found that all melanoma-
associated CD90þ MCs secreted high levels of CCL2, com-
pared with control CD90þ MCs purified from normal skin or
with tumor-infiltrating lymphocytes (Figure 2c; Supplementary
Figure S4c online). Furthermore, the chemotactic activity was
abolished with neutralizing anti-CCL2 and anti-CCR2 mAbs
(Figure 2d).
To compare the ability to express CCL2 and its receptor
CCR2 by different tumor tissue components, we performed
quantitative PCR analysis (Figure 2e). In contrast to the stable
CCL2 mRNA and protein expression maintained by CD90þ
MCs in culture, patient-derived melanoma TCs expanded
in vitro did not express CCL2 (Figure 2e and f;
Supplementary Figure S4e online). However, CCL2 mRNA
and protein expression was inducible in TCs upon stimulation
with transforming growth factor-b1/tumor necrosis factor-a,
and CCL2 protein was specially accumulated in the peri-
nuclear region of the stimulated TCs, colocalizing with Golgi
markers (Figure 2f; and not shown). ‘‘Total tumor’’ tissues
barely expressed CCR2, and no expression was detected by
CD90þ MCs and TCs expanded in vitro (Figure 2e and f).
CCR2 mRNA and protein expressions were restricted to
peripheral blood monocytes (Figure 2e; Supplementary
Figure S4d online), whereas tumor-associated macrophages
(TAMs) purified directly from melanoma highly expressed
CCL2, but not CCR2 (Figure 2e).
CCL2/CCR2 expression in melanoma tissue
Next, we explored CCL2 and CCR2 protein expression on
tissue sections of metastatic and primary lesions (Figure 3).
Most tumor and nontumoral cells, including endothelial cells
and perivascular MCs, consistently displayed CCL2 staining in
all metastatic samples studied (22/22), showing a major
accumulation in a perinuclear region colocalizing with Golgi,
as well as in small vesicles (Figure 3a; Supplementary Figure
S4f online). Regardless of this general CCL2 overexpression,
very few cells in metastatic tissues expressed the receptor
CCR2, usually CD45þ cells localized in the proximity
of peritumoral vessels (Figure 3aD).
Similar to metastatic melanoma, a large expansion of
DARCþ dermal vessels heavily surrounded by CD90þ MCs
was observed in invasive Clark II–V primary cutaneous
melanomas at the base of the lesion (Figure 3b;
Supplementary Figure S4g online). In contrast, noninvasive
intraepithelial Clark I melanomas displayed much fewer
peritumoral dermal vessels (B10-fold less), which contained
some CD90þ perivascular cells (Supplementary Figure S4h
online). Similar to control skin, Clark I melanomas showed
minor CCL2 expression associated with dermal vessels but
displayed enhanced CCL2 expression at the basal layer of the
epidermis (Supplementary Figure S4h online). An impressive
CCL2 staining of peritumoral vessels, which were heavily
surrounded by CD90þ MCs, was detected in invasive Clark
II–V melanomas (Figure 3b). The density of peritumoral vessels
positively correlated with leukocyte infiltration at the base or
around primary lesions (Supplementary Figure S4i online),
which is in line with previous results (Kiss et al., 2007).
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In primary tumors, CCR2 expression was also restricted to a
minor population of CD45þ cells located in the peritumoral
stroma (o10%, Supplementary Figure S6a online), further
suggesting that inflammatory CCR2þ leukocytes may be
recruited from the blood at the peritumoral stroma.
Tumor co-infiltration of MCs and immune cells
Next, we focused on the variable presence of intratumoral
leukocytes infiltrating among melanoma cells, which were
detected in certain specimens, irrespective of CCL2 over-
expression by TCs in all samples, indicating no association
between general CCL2 expression and deep leukocyte infiltra-
tion of tumor islets (Supplementary Figure S6b and c online).
To search for additional factors guiding the intratumoral
position of leukocytes, we performed a multiparametric
quantitative analysis that showed a strong positive correlation
between intratumoral leukocytes and COL1 content
(Figure 4a). Furthermore, the difference in leukocyte density
was significant between the two groups of low/high intratu-
moral FAP (Po0.001, Figure 4b), suggesting that stromal cell/
ECM networks could have a major role in the intratumoral
infiltration of leukocytes. To illustrate this relationship, we
show two inversely infiltrated intratumoral areas within the
same metastatic macroscopic lesion (intratumoral heterogene-
ity), which displayed low and high intratumoral CD45þ
leukocyte infiltration and their corresponding COL1 staining
(Figure 4c). Similarly, a COL1/FN network was detected
colocalizing with FAPþ cells in some thick primary cutaneous
melanomas (4/9, tumor thickness or Breslow 42 mm), which
correlated positively with intratumoral CD45þ leukocytes
(Supplementary Figure S7a online). Next, we quantitatively
assessed the position of infiltrating leukocytes with regard to
COL1 networks (Supplementary Table S3 online). Detailed
image analysis and quantification showed that most intratu-
moral leukocytes (B90%) were in close contact with COL1
networks, irrespective of COL1 content in each specimen that
ranged from 1 to 35% of tumor area (Figure 4d;
Supplementary Table S3 online). Thus, in FAP-negative cases,
intratumoral leukocytes were usually detected in contact with
the perivascular COL1-connective sheet. These results suggest
an interdependence of intratumoral mesenchymal and inflam-
matory immune cell infiltrates.
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Figure 2. Ex vivo expression of CCL2/CCR2. (a) CD90, fibroblast activation protein (FAP), NG2, and Hmb45 expression levels in tumor cells (TCs)1 and
mesenchymal cells (MCs)1, as assessed by flow cytometry. Images correspond to TCs19 and MCs19 stained for FN (red) and nuclei (white). (b) Peripheral blood
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PB, peripheral blood.
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A stromal-dependent melanoma xenograft model increases
tumor infiltration of leukocytes
To provide mechanistic studies on the mesenchymal contribu-
tion to leukocyte positioning within tumors, we established an
experimental tumor model in which the human melanoma
A375 cell line was either mixed or not with patient-derived
MC, and injected subcutaneously on opposite flanks of nude
mice (Figure 5a). We first monitored the extent of stromal
networks from either human or mouse origin in early
primary tumors to minimize the impact of mouse stromal
recruitment during tumor progression. As expected, we found
well-organized FAPþ /FN networks, full of macrophages
and neutrophils in ‘‘TCþMC’’ tumors. Correspondingly,
‘‘TC only’’ contralateral tumors were poor in FN stroma and
macrophage and neutrophil content, despite the similar
upregulation of CCL2 expression by the TCs (Figure 5a). Next,
we investigated the efficacy of adoptive T-cell transfer recruit-
ment into tumor-bearing mice after 6 days of intravenous
administration. We found increased infiltration of ‘‘TCþMC’’
tumors with activated CD8þ mouse T cells, compared with
contralateral ‘‘TC only’’ tumors.
To directly explore the mechanism behind the stromal
regulation of lymphocyte recruitment, we performed more
simplistic in vitro T-cell migration assays along TC or TCþ
MC-mixed monolayers (Supplementary Figure S7b online).
We layered the activated human T cells on the surface of these
monolayers and followed their behavior after 1 h of contact by
time-lapse video microscopy. Interestingly, the pattern
of T-cell migration differed substantially (Figure 5b). T cells
on top of TCþMC monolayers migrated faster and followed
straighter paths, accounting for significantly greater displace-
ment rate, compared with T cells on top of TC monolayers. All
these motility parameters were not modified when T cells
were preincubated with pertussis toxin, indicating the inde-
pendence of Gi-mediated chemokine signals (Figure 5b).
Migration on top of either TC or TCþMC monolayers
appeared to be dependent on integrins, as it was completely
blocked by T-cell preincubation with inhibitory anti-b1 plus
anti-b2 antibodies (Supplementary Figure S7b online). These
results indicate that MCs support fast and directed migration of
T lymphocytes. Thus, improved T-cell motility programs
provided by MCs may account for the enhanced infiltration
of TCþMC tumors by adoptive transferred T cells.
DISCUSSION
Multiparametric confocal analysis presented here docu-
ment major differences between tumor and peritumoral
compartments (Figure 6). Consistent with previous work
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Figure 3. CCL2/CCR2 expression in melanoma tissues. (a) Metastasis no. 223 (see Figure 1a) stained as follows: (A) CCL2 (white) and CD31 (red); (B) CD68
(white); (C) CCL2 (white), CD31 (red), and CD90 (green); and (D) CCL2 (white), CCR2 (green), CD45 (red), and nuclei (blue); images are z-stack projections, and
vessel contour is depicted. Arrows along panels point to the same peritumoral vessel. (b) Clark II (no. 158) lesion stained in consecutive sections for Hmb45, CD90,
von Willebrand factor (vWF), CD31, Duffy antigen receptor for chemokine (DARC), CCL2, and nuclei, as indicated. Magnified peritumoral vessels surrounded by
CCL2þCD90þ mesenchymal cells (MCs) are shown on the right. Cyan-dotted lines indicate the tumor border. Scale bars, as indicated. DAPI, 40,6-diamidino-2-
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(Martinet et al., 2011), we show the presence of specialized
postcapillary vessels for leukocyte extravasation, characterized
by DARCþ -high endothelial cells, in the peritumoral stroma
of melanoma lesions but not in intratumoral areas. We show
that peritumoral vessels are heavily surrounded by a particular
kind of CD90þ MC, which maintained a CCL2-secretory
phenotype when expanded ex vivo, indicating a stable pro-
inflammatory signature. In addition to its signaling receptor
CCR2, CCL2 binds to the atypical receptor DARC, which is
involved in the transendothelial transport of inflammatory
chemokines (Pruenster et al., 2009). Thus, CCL2 secreted by
perivascular CD90þ MCs may be captured at the abluminal
surface of endothelial cells by DARC and presented at the
luminal lining (Bao et al., 2010). Furthermore, CD90 itself is a
counter receptor for integrin Mac1 (CD11bCD18) and CD97,
both expressed by myeloid cells (Wetzel et al., 2004; Wandel
et al., 2012), and is involved in the control of inflammatory
cell recruitment (Schubert et al., 2011). A striking fading of
CD90 expression at the tumor–stroma border, coincident with
a large accumulation of leukocytes, may suggest that CD90 is
downregulated by a tumor-induced mechanism to evade the
inflammatory immune response. Intriguingly, MCs lacked the
expression of CD90 in TCþMC tumors in vivo, but not in
TCþMC cocultured in vitro (Supplementary Figure S7b and c
online). Irrespective of general expression of CCL2, the
restricted expression of its receptor CCR2 to monocytes and
certain leukocytes suggests that CCL2 predominantly partici-
pates in CCR2þ leukocyte extravasation from peripheral
blood and not in further interstitial positioning of macro-
phages. Indeed, we show that TAMs isolated from human
melanoma do not express CCR2 but highly express CCL2.
Accordingly, it has been previously reported that CCR2 is
downregulated during macrophage differentiation (Sica et al.,
2000; Yiakouvaki et al., 2012). Migration of myeloid cells out
of the perivascular space may involve other chemokine
receptors expressed by TAMs such as CCR1 and CCR5
(Mantovani et al., 2004), or could be independent of
chemokines and relay on adhesive interactions with stromal
components.
Previous intravital microscopy of tumors showed the migra-
tion of T cells in close contact with ECM fibers (Mrass et al.,
2006; Boissonnas et al., 2007). Similar studies demonstrated
that the stromal microanatomy of two distinct MC types,
fibroblastic reticular cells and follicular dendritic cells, guide
and delimit the movements of naive T and B lymphocytes,
respectively, within the densely packed environment of lymph
nodes (Bajenoff et al., 2006). Similar guidance of aligned
fibers appears to control T-lymphocyte migration within
peritumoral stroma, whereas T cells migrate poorly
within tumor islets or in dense matrix areas adjacent to
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mFAP (no. 93.1) and kFAP (no. 93.3) stained for COL1, von Willebrand factor (vWF) and CD45, as indicated. (d) kFAP (no. 97) and mFAP
(no. 223) metastases co-stained for CD45, COL1, and vWF, as indicated. Bars¼ 100mm. DAPI, 40,6-diamidino-2-phenylindole; NS, not significant.
R Samaniego et al.
Mesenchymal Contribution to Leukocyte Infiltration
2260 Journal of Investigative Dermatology (2013), Volume 133
tumors (Salmon et al., 2012). Similarly, we found large
leukocyte accumulation in the peritumoral stroma of human
melanoma tissues, compared with sparse infiltration within
tumor islets. However, we found some human melanoma
tissues distinctively infiltrated by intratumoral leukocytes, in
accordance with other works (Erdag et al., 2012). Interestingly,
we show a preferential localization of leukocytes in close
contact with a distinctive stromal cell/ECM network
developed in some intratumoral areas. The existence of
intricate fibrillar networks or channels around TCs has been
previously described in the transition from micro-invasive
toward deeply invasive primary melanomas, as well as in
metastatic melanoma and breast cancer (Kaariainen et al.,
2006; Soikkeli et al., 2010). These fibrillar networks have been
proposed to regulate the adhesion, migration, and growth of
TCs, and contain specific matrix proteins such as tenascin-C.
Here we show that tumor areas devoid of stromal cell/ECM
networks contain minor intratumoral leukocyte infiltration,
whereas most intratumoral leukocytes are in close contact
with ECM components. These results suggest that stromal
cell/ECM scaffolds provide an effective haptokinetic support
for guiding leukocyte infiltration of compact tumor islets,
which are minimally penetrated in their absence.
Therefore, to establish a cause–effect relationship in the
association of intratumoral leukocytes and stromal cell/ECM
networks, we developed a xenograft model of human mela-
noma in nude mouse, in which the composition of intra-
tumoral stroma may be modified by adding MCs, and
T lymphocytes may be acutely transferred. Indeed, we observed
structural similarities between stromal networks developed in
TCþMC tumors, which were highly infiltrated by macro-
phages and neutrophils, and intratumoral networks detected in
some mixed areas of human melanoma tumors. Similar
enhancement in macrophage infiltration has been observed
in squamous skin tumors co-injected with cancer-associated
fibroblasts (Erez et al., 2010). Remarkably, more adoptively
transferred CD8 T cells were recruited into the stromal cell/
ECM networks of ‘‘TCþMC’’ tumors. Finally, we show that
parameters of T-cell migration on top of TC versus TCþMC-
mixed monolayers are largely different, suggesting that
MCs may provide confined tracks for fast and directionally
persistent migration of T cells. Altogether, these data indicate
that MCs form routes (cellular and matrix components) for
efficient leukocyte infiltration of tumors.
As tumors are complex tissues, composed of TCs and a
multitude of nontumor cells often separated in two regions,
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Figure 5. Mesenchymal cells (MCs) promote leukocyte infiltration of melanoma xenografts in vivo and T-lymphocyte migration in vitro. (a) A375±MCs19 were
subcutaneously inoculated at opposite flanks of nude mice (n¼ 5), as shown in the scheme. Contralateral tumors were compared for fibroblast activation protein
(FAPþ ) MC and fibronectin (FN) content, host F4/80þ , and Gr1þ -cell infiltration, CD31þ vessel density, and infiltration of transferred CD8þ T cells. Three
intratumoral fields by tumor were quantified and significant differences are shown (Wilcoxon). Representative images of the two tumor groups stained for CCL2,
FN, FAP (host and human), F4/80, CD8a, and DAPI are shown, as indicated. (b) Human T lymphoblasts were allowed to migrate for 1 h along A375±MC19
monolayers. Representative tracks (frame minute1, left) and dot plots of net displacement, mean velocity, and migratory persistence of T cells pretreated
±pertussis toxin (PTX). Mean ±SEM (n¼ 65 cells per condition) and significant differences (Mann–Whitney) are shown. Data correspond to one representative
assay out of three. (c) Simultaneous chemotactic assay as control of PTX effect. DAPI, 40,6-diamidino-2-phenylindole; NS, not significant; TC, tumor cell.
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the tumor parenchyma and the peritumoral stroma, but
remarkably mixed in particular cases, the question arises:
what determines the intratumoral position of some leukocytes
and MCs, that is, which cells initiate the invasion of the
opposite neighborhood? As depicted in Figure 6a, our data
support a model in which penetration of leukocytes among
TCs, which are densely packed cell environments, may rely on
the adhesive support provided by tumor-infiltrating stromal
networks (cellular and matrix). Understanding of the mechan-
isms by which stroma modulates recruitment and function of
leukocytes in tumors will be important to develop therapeutic
tools. Furthermore, our results demonstrate a change in the
phenotype of MCs, following a spatial gradient (Figure 6b).
Whether these various phenotypes correspond to different
MC subpopulations or reflect a process of migration and
differentiation from the perivascular niche, which contains a
reserve of progenitor MCs (Crisan et al., 2008), to the
peritumoral and intratumoral areas will require further
investigation.
MATERIALS AND METHODS
Cells and antibodies
Human melanoma TCs and MCs were isolated from biopsied
metastatic lesions. Tumor pieces were homogenized and CD90þ
MCs were purified using fluorescence-activated cell sorting (MoFlo-
Astrios FACS; Beckman Coulter, Madrid, Spain). All positively and
negatively sorted TCs, A375 melanoma cells (American Type Culture
Collection, Barcelona, Spain), and CD90þ cells derived from control
skin were grown in RPMI-1640 medium (Gibco, Alcobendas, Spain),
supplemented with 10% fetal calf serum (FCS, Sigma-Aldrich,
Madrid, Spain). Melanoma–TAM and peripheral blood mononuclear
cells were obtained as previously described (Puig-Kroger et al., 2009;
Sanchez-Martin et al., 2011). The antibodies used in this study are
specified in Supplementary Table S1 online.
Quantitative PCR analysis
Oligonucleotides for selected genes (CCL2, CCR2a, and CCR2b) were
designed according to the Roche software for quantitative real-time
PCR. Total RNA was extracted (RNeasy kit; Qiagen, Madrid, Spain),
retrotranscribed, and cDNAs were quantified using the Universal
Human Probe Roche library (Roche-Diagnosis, Madrid, Spain).
Assays were performed in triplicate, and results were normalized to
TATA-binding protein expression (DDCT method).
Fluorescence confocal microscopy
Melanoma tissues were obtained from patients with primary and
metastatic lesions undergoing surgical treatment, and the study was
conducted according to the Declaration of Helsinki Principles.
Cryosections (4mm) were fixed with 5% acetone and analyzed. Over
50 melanoma samples were screened, selecting 37 suitable cases
(22 metastases and 15 primary melanomas) with quantifiable regions
of both tumor and peritumoral stroma. For in vitro cell imaging, cells
were plated on coverslips. When mentioned, cells were incubated
with tumor necrosis factor-a/transforming growth factor-b1 (Prepro-
Tech, Madrid, Spain). FN deposition was imaged after 8 days in
RPMI-1640 with 10% FCS and 50mg ml 1 ascorbic acid (Sigma-
Aldrich). Imaging was performed using an inverted confocal fluores-
cence microscope (SP2; Leica Microsystems, Heidelberg, Germany):
 10 PL-APO numerical aperture (NA) 0.4 objective was used for
panoramic images; glycerol-immersion  20 PL-APO NA 0.7 objec-
tive was used for tissue screening and image quantification; and  63
PL-APO NA 1.3 glycerol-immersion objective for detailed imaging.
Leukocyte and vessel densities were manually counted at  20 fields
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Figure 6. Organization of poorly and highly infiltrated melanomas. (a) All
melanoma tissues analyzed in this study can be classified in one of these two
schematic groups. Tumors poorly infiltrated by leukocytes (o500 cells per
mm2) are also poorly infiltrated by mesenchymal cells (MCs), showing variable
densities of both small and large vessels; on the contrary, highly leukocyte-
infiltrated tumors are characterized by a distinctive fibro-cellular network
of extracellular matrix (ECM) and MC (fibroblast activation protein
(FAPþ )CD90low/ ), where most leukocytes (B90%) contact ECM fibrils while
they face the neighbor tumor cells (TCs). Peritumoral stroma is quite similar in
both scenarios: it is rich in elongated MCs (FAPþCD90þ ) and leukocytes
(42,000 cells per mm2) and contains vessels surrounded by perivascular
MCs (FAPCD90hi), many of them with a DARCþ endothelium (B40%).
(b) Phenotype transition (CD90/FAP) from perivascular to peritumoral and
intratumoral MCs.
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(0.55 mm2), and MC/ECM parameters were assessed with the Leica
software (LCS-1537).
ELISA
Cell culture supernatants were collected after 24 h incubation of
105 cells per well in RPMI-1640 medium with 10% FCS. Secretion of
CCL2, CCL3, CCL4, and CCL5 were assessed in triplicate, using kits
from R&D (Madrid, Spain).
Migration assays
Transendothelial and chemotactic assays were performed in triplicate
in transwell chambers (Bionova Cientifica, Madrid, Spain), as pre-
viously described (de la Rosa et al., 2003). Recombinant human
CCL2 and CXCL12 were from PreproTech. For in vitro migration
assays, A375 ±MC19 cells were cultured for 5 days in RPMI-1640
10% FCS until they formed confluent monolayers. Activated T
lymphocytes were obtained from PBLs sequentially incubated with
4mg ml 1 Phytohemagglutinin-M (Roche-Diagnosis) for 2 days,
and 20 U ml 1 rhIL-2 (Novartis-Diagnostics, Basel, Switzerland) for
10 days. T cells were pretreated with 100 ng ml 1 pertussis toxin
(Sigma-Aldrich) for 2 h or 20mg ml 1 anti-b1/b2 blocking antibodies
(VJ1/14, TS1/18) for 30 minutes. Coverslips were placed within video
chambers containing medium without FCS, and T cells were added
on top. After 1 h incubation, time-lapse imaging was performed.
Imaris software (Bitplane, Zurich, Switzerland) was used for tracking
measurements.
Melanoma xenograft model
BALB/cOlaHsd-Foxn1nu mice (Harlan-Laboratories, Santiga, Spain),
maintained under specific pathogen-free conditions, were subcuta-
neously inoculated with 106 A375 melanoma cells (left flank), and
106 A375 cells were mixed with 106 MC19 (right flank). After 7 days,
mice were intravenously transferred with 5 106 activated CD8þ
T cells. At day 13, mice were killed and tumors were extracted.
Lymphoblasts were obtained incubating splenocytes (from BALB/cH-
2d mice) with 250mg ml 1 Concanavalin-A (Sigma-Aldrich) for 2
days, and 500 U ml 1 rhIL-2 for 6 days. CD8þ cells were purified
with an isolation kit (Miltenyi-Biotec, Madrid, Spain). The medical
ethical committee of IiSGM approved all described studies.
Statistical analyses
Pearson’s correlation, Mann–Whitney, Wilcoxon, and Student’s t-tests
were conducted when indicated.
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